Swiss drugmaker Roche said on Thursday its first-quarter sales rose a forecast-beating 7% driven by breast cancer drug Phesgo ...

By Ludwig Burger (Reuters) -Swiss drugmaker Roche is petitioning the U.S. government in direct talks for import tariff ...

Roche posted higher first-quarter sales that beat analysts’ expectations on higher demand for its key drugs. The Swiss ...

Roche will invest $50 billion in U.S. manufacturing, including a new plant in Indiana. The Trump administration is ...

The move will also create 12,000 new jobs across the United States, with 6,500 in construction and 1,000 at “new and expanded ...

Roche said on Tuesday it would invest $50 billion in the United States over the next five years, creating more than 12,000 ...

Roche’s exposure to the tariffs is mostly limited to four medicines, three of which it already produces in the U.S., ...

Roche is working to mitigate potential impacts from tariffs by moving production of its medicines to the U.S. and petitioning ...

The Basel-based company said the investment would go toward high-tech research and development sites and new manufacturing ...

Roche posted a Q1 revenue beat, with strong contributions from Phesgo, Xolair, and Polivy, despite larger products lagging.

The pharma giant said the investment would create more than 12,000 jobs, as it joins rival Novartis in expanding its ...